SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
- Canadian Biotechnology Company updates progress and upcomingmilestones on its insulin program - CALGARY, June 26, 2007 /PRNewswire-FirstCall/ - SemBioSysGenetics Inc. , a biotechnology company developing a portfolio oftherapeutic proteins for metabolic and cardiovascular disease,today announced positive preclinical data supporting thedevelopment of plant-derived recombinant human insuli...SemBioSys to present new data at American Diabetes Association annual meeting
TSX symbol: SBS CALGARY, June 20, 2007 /PRNewswire-FirstCall/ - SemBioSysGenetics Inc. , a biotechnology company developing a portfolio oftherapeutic proteins for metabolic and cardiovascular disease,today announced that it will be presenting a scientific poster andabstract at the 67th Scientific Sessions of the American DiabetesAssociation (ADA) in Chicago. The Company's poster will disc...